Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yanmin Wang, Yanli Meng, Shijun Zhang, Huancheng Wu, Dawei Yang, Chaohui Nie & Qunliang Hu. (2018) Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo. OncoTargets and Therapy 11, pages 6039-6048.
Read now
Read now
Articles from other publishers (34)
Swati Sonal, Chloe Boudreau, Hiroko Kunitake, Robert N. Goldstone, Grace C. Lee, Christy E. Cauley, Liliana G. Bordeianou, Todd D. Francone, Rocco Ricciardi & David L. Berger. (2023) Metformin Does not Affect Outcomes in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Therapy and Resection. The American Surgeon™.
Crossref
Crossref
I. V. Druk, E. A. Lyalyukova & E. A. Fadeeva. (2022) Metformin in the prevention of colorectal cancer with diabetes mellitus. Experimental and Clinical Gastroenterology:9, pages 161-170.
Crossref
Crossref
Alaa Ibrahim, Islam A. Khalil & Ibrahim M. El-Sherbiny. (2022) Development and Evaluation of Core-Shell Nanocarrier System for Enhancing the Cytotoxicity of Doxorubicin/Metformin Combination Against Breast Cancer Cell Line. Journal of Pharmaceutical Sciences 111:9, pages 2581-2591.
Crossref
Crossref
Shu-Hua Hsu, De-Kai Syu, Yu-Chiao Wang, Chih-Kuang Liu & Ming-Chih Chen. (2022) Metformin, Statin Use, and Female Colorectal Cancer: A Population-Based Cohort Study in Taiwan. Journal of Clinical Medicine 11:15, pages 4469.
Crossref
Crossref
Wenxuan Xiao, Jinglong Huang, Chuanyi Zhao, Lu Ding, Xuan Wang & Bian Wu. (2022) Diabetes and Risks of Right-Sided and Left-Sided Colon Cancer: A Meta-Analysis of Prospective Cohorts. Frontiers in Oncology 12.
Crossref
Crossref
Xinhua Chen, Yuehong Chen, Tao Li, Weiqi Liang, Huilin Huang, Hongtao Su, Chuyang Sui, Yanfeng Hu, Hao Chen, Tian Lin, Tao Chen, Liying Zhao, Hao Liu, Guoxin Li & Jiang Yu. (2022) Diabetes mellitus promoted lymph node metastasis in gastric cancer: a 15–year single-institution experience. Chinese Medical Journal 135:8, pages 950-961.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
535
592
.
Rhea Harewood, Ruth Disney, James Kinross, Christian von Wagner & Amanda J. Cross. (2021) Medication use and risk of proximal colon cancer: a systematic review of prospective studies with narrative synthesis and meta-analysis. Cancer Causes & Control 32:10, pages 1047-1061.
Crossref
Crossref
Sami Erkinantti, Mikko Marttila, Reijo Sund, Martti Arffman, Elina Urpilainen, Ulla Puistola, Ari Hautakoski, Peeter Karihtala, Esa Läärä & Arja Jukkola. (2021) Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes. Clinical Colorectal Cancer 20:2, pages e113-e119.
Crossref
Crossref
Kui Zhang, Peng Bai, Hao Dai & Zhenhua Deng. (2021) Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Primary Care Diabetes 15:1, pages 52-58.
Crossref
Crossref
H.-D. Wu, J.-J. Zhang & B.-J. Zhou. (2020) The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta‑analysis. Clinical and Translational Oncology 23:2, pages 275-282.
Crossref
Crossref
Qi-You Huang, Fei Yao, Chuan-Ren Zhou, Xiao-Ying Huang, Qiang Wang, Hui Long & Qing-Ming Wu. (2020) Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes. World Journal of Clinical Cases 8:24, pages 6213-6228.
Crossref
Crossref
Taryn E. Hassinger, Adam C. Berger, Adrienne Christopher, Anne T. Knisely, J. Hunter Mehaffey, David R. Brenin, Anneke T. Schroen & Shayna L. Showalter. (2020) Diabetes Mellitus and Metformin Are Not Associated With Breast Cancer Pathologic Complete Response. Journal of Surgical Research 247, pages 52-58.
Crossref
Crossref
Cheol Min Shin, Nayoung Kim, Kyungdo Han, Bongseong Kim, Jin Hyung Jung, Tae Jung Oh & Dong Ho Lee. (2020) Anti-diabetic medications and the risk for colorectal cancer: A population-based nested case-control study. Cancer Epidemiology 64, pages 101658.
Crossref
Crossref
Sónia Pires Celeiro, Fátima Baltazar & Marta Viana-Pereira. 2020. Biomaterials for 3D Tumor Modeling. Biomaterials for 3D Tumor Modeling
131
155
.
Ali R. Nasiri, Marcos R. Rodrigues, Zongyu Li, Brooks P. Leitner & Rachel J. Perry. (2019) SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia. Cancer & Metabolism 7:1.
Crossref
Crossref
Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin-Rong Zhou & Ishwar Parhar. (2019) Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Joshua DembArmaan YaseyyediLin LiuRanier BustamanteAshley EarlesPradipta GhoshJ. Silvio GutkindAndrew J. GawronTonya R. KaltenbachMaria Elena MartinezSamir Gupta. (2019) Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes. Clinical and Translational Gastroenterology 10:11, pages e00092.
Crossref
Crossref
Teguh Kristian Perdamaian. (2019) Recent evidence on modifiable and non-modifiable risk factors for colorectal cancer (CRC): a systematic synopsis of meta-analyses from 2015 to 2017. Medical Journal of Indonesia 28:2, pages 188-95.
Crossref
Crossref
Yuan He, Shanshan Tai, Miao Deng, Zhaona Fan, Fan Ping, Lihong He, Chi Zhang, Yulei Huang, Bin Cheng & Juan Xia. (2019) Metformin and 4SC‐202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma. Cancer Medicine 8:7, pages 3479-3490.
Crossref
Crossref
Junichi Kato, Yohei Shirakami & Masahito Shimizu. (2019) Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs. Gastrointestinal Disorders 1:2, pages 273-289.
Crossref
Crossref
Sylvia Andrzejewski, Peter M. Siegel & Julie St-Pierre. (2018) Metabolic Profiles Associated With Metformin Efficacy in Cancer. Frontiers in Endocrinology 9.
Crossref
Crossref
Yongliang Wang, Ali R. Nasiri, William E. Damsky, Curtis J. Perry, Xian-Man Zhang, Aviva Rabin-Court, Michael N. Pollak, Gerald I. Shulman & Rachel J. Perry. (2018) Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer. Cell Reports 24:1, pages 47-55.
Crossref
Crossref
Nobufumi Sekino, Masayuki Kano, Yasunori Matsumoto, Haruhito Sakata, Yasunori Akutsu, Naoyuki Hanari, Kentaro Murakami, Takeshi Toyozumi, Masahiko Takahashi, Ryota Otsuka, Masaya Yokoyama, Tadashi Shiraishi, Koichiro Okada, Isamu Hoshino, Keiko Iida, Aki Komatsu Akimoto & Hisahiro Matsubara. (2018) Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma. Cancer Science 109:4, pages 1066-1074.
Crossref
Crossref
Ariella De Monte, Davide Brunetti, Luigi Cattin, Francesca Lavanda, Erica Naibo, Maria Malagoli, Giorgio Stanta & Serena Bonin. (2018) Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients. Molecular and Clinical Oncology.
Crossref
Crossref
Mitchell B. Lee & Matt Kaeberlein. (2018) Translational geroscience: From invertebrate models to companion animal and human interventions. Translational Medicine of Aging 2, pages 15-29.
Crossref
Crossref
Marinko Marušić, Rosana Troskot Perić & Antonio Klemenčić. 2018. Gastrointestinal Complications of Diabetes. Gastrointestinal Complications of Diabetes
145
161
.
Salah Eddine El Herrag, Youssouf Traoré & Méghit Boumediène Khaled. (2017) Metabolic syndrome and risk of colorectal adenoma and colorectal cancer: a meta-analysis. The North African Journal of Food and Nutrition Research 1:2, pages 30-45.
Crossref
Crossref
Magdalena Szaryńska, Agata Olejniczak, Jarosław Kobiela, Piotr Spychalski & Zbigniew Kmieć. (2017) Therapeutic strategies against cancer stem cells in human colorectal cancer (Review). Oncology Letters.
Crossref
Crossref
Shan Tian, Hong‐Bo Lei, Yu‐Lan Liu, Yan Chen & Wei‐Guo Dong. (2017) The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta‐analysis. Chronic Diseases and Translational Medicine 3:3, pages 169-175.
Crossref
Crossref
Brandy M. Heckman-Stoddard, Andrea DeCensi, Vikrant V. Sahasrabuddhe & Leslie G. Ford. (2017) Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia 60:9, pages 1639-1647.
Crossref
Crossref
Mirabella Zhao, Donghua Liao & Jingbo Zhao. (2017) Diabetes-induced mechanophysiological changes in the small intestine and colon. World Journal of Diabetes 8:6, pages 249.
Crossref
Crossref
Zhihui Xiao, Wenjun Wu & Vladimir Poltoratsky. (2017) Metformin Suppressed CXCL8 Expression and Cell Migration in HEK293/TLR4 Cell Line. Mediators of Inflammation 2017, pages 1-11.
Crossref
Crossref
Fanqiang Meng, Li Song & Wenyue Wang. (2017) Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis. Journal of Diabetes Research 2017, pages 1-8.
Crossref
Crossref